Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle‐invasive bladder cancer
Alva, Ajjai S.; Tallman, Christopher T.; He, Chang; Hussain, Maha H. A.; Hafez, Khaled S.; Montie, James E.; Smith, David C.; Weizer, Alon Z.; Wood, David; Lee, Cheryl T.
2012-01-01
Citation
Alva, Ajjai S.; Tallman, Christopher T.; He, Chang; Hussain, Maha H.; Hafez, Khaled; Montie, James E.; Smith, David C.; Weizer, Alon Z.; Wood, David; Lee, Cheryl T. (2012). "Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle‐invasive bladder cancer." Cancer 118(1): 44-53. <http://hdl.handle.net/2027.42/89461>
Abstract
BACKGROUND: Cystectomy delay >90 days after a diagnosis of muscle‐invasive bladder cancer (MIBC) adversely affects pathologic stage and survival outcomes in patients who undergo primary surgery. After neoadjuvant chemotherapy (NAC), the impact of the timing of cystectomy delivery on these outcomes is uncertain. Poor communication between urologic and medical oncologists can result in cystectomy delay after systemic treatment. The authors of this report hypothesized that a delay in cystectomy delivery after NAC is associated with adverse survival outcomes. METHODS: An eligible cohort of 153 patients with MIBC received NAC and underwent radical cystectomy between 1990 and 2007. At the authors' institution, the genitourinary team strives to schedule patients for surgery at the time of initial evaluation or after their first chemotherapy cycle. Clinicopathologic characteristics, including timing of cystectomy, chemotherapy delivery, vital status, and reasons for excessive surgical delay, were analyzed retrospectively using an institutional database. A Cox proportional regression model was used to test the association between the timing of cystectomy delivery and survival. RESULTS: The median follow‐up for all patients was 3.6 years. The median time to cystectomy was 16.6 weeks and 6.9 weeks from the first and last day of NAC, respectively. In multivariate analyses, the timing of cystectomy delivery from the termination of NAC did not significantly alter the risk of survival. The most common reason for cystectomy delivery beyond 10 weeks (28 patients; 18%) was procedural scheduling. CONCLUSIONS: Cystectomy delivery within 10 weeks after NAC did not compromise patient survival and, thus, provided a reasonable window for patient recovery and surgical intervention. Cancer 2012;. © 2011 American Cancer Society. The authors analyzed the timing between the termination of neoadjuvant chemotherapy and cystectomy and assessed its impact on the survival of patients with muscle‐invasive bladder cancer. By using a multidisciplinary approach, the authors determined that the median time to cystectomy was 6.9 weeks. The results indicated that undergoing cystectomy within 10 weeks after the completion of neoadjuvant chemotherapy did not compromise cancer‐specific or overall survival.Publisher
Wiley Subscription Services, Inc., A Wiley Company
ISSN
0008-543X 1097-0142
Other DOIs
PMID
21598245
Types
Article
Metadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.